Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZOSTAVAX Concomitant with Influenza Vaccine
NCT02519855Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2015
- Primary completion
- Jan 2016
- Modality
- Live Attenuated Vaccines
01
Overview
A Phase 3 trial of varicella virus vaccine live in herpes zoster (HZ), sponsored by Merck & Co.. Started Sep 2015; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT02519855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02519855.